{
  "id": "5e776cfe835f4e4777000010",
  "type": "factoid",
  "question": "When was Afrezza approved by the FDA?",
  "ideal_answer": "Afrezza was approved by the FDA in June 2014.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/26222134"
  ],
  "snippets": [
    {
      "text": "In contrary, MannKind Corporation started developing its ultra-rapid-acting insulin Afrezza in a bold bid, probably by managing the issues in which Exubera was not successful. Afrezza has been marketed since February, 2015 by Sanofi after getting FDA approval in June 2014.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26222134",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "June 2014"
}